Results for ctc translation from English to Croatian

ctc grade
ctca stupanj

ctc grade 2
ctc stupanj 2

nci-ctc grade
nci-ctc stupanj

grade (ctc-ae)*
stupanj (ctc-ae)

ctc grade 3 or 4
ctc stupanj 3 ili 4

toxicity (nci ctc v 2.0)*
toksičnost (nci ctc v 2.0)

grade (ctc-ae) (a)
stupanj (ctc-ae) (a)

all irrs were ctc grade 1 or 2.
sve su infuzijske reakcije bile 1. ili 2. stupnja prema ctc kriterijima.

asthenia, predominantly mild (ctc grade 1).
astenija, pretežno blaga (ctc stupanj 1)

anorexia mild or moderate (ctc grade 1 or 2).
anoreksija blaga ili umjerena (ctc stupanj 1 ili 2).

stomatitis, predominantly mild in nature (ctc grade 1).
stomatitis, pretežno blag (ctc stupanj 1).

the 15-member ctc was established to monitor implementation of the resolution.
ctc, u čijem je sastavu 15 članova, uspostavljen je kako bi nadzirao provedbu rezolucije.

diarrhoea, mainly mild or moderate (ctc grade 1 or 2).
proljev, većinom blag ili umjeren (ctc stupanj 1 ili 2).

2 nci ctc grade 3 nausea is defined as no significant intake, requiring intravenous fluids.
2 mučnina 3. stupnja prema kriterijima nci ctc definira se kao neznačajan unos koji zahtijeva intravensku primjenu tekućine.

ctc non-haematological toxicity (except for alopecia, nausea, vomiting)
ctc stupanj nehematološke toksičnosti (osim alopecije, mučnine i povraćanja)

a national cancer institute common toxicity criteria (ctc v2.0; nci 1998)
a zajednički kriteriji toksičnosti nacionalnog instituta za rak (ctc v2.0; nci 1998)

conjunctivitis, blepharitis, and dry eye*, mainly mild (ctc grade 1).
konjunktivitis, blefaritis i suhoća oka*, uglavnom blagi (ctc stupanj 1).

a national cancer institute common toxicity criteria (ctc v2.0; nci 1998) b excluding neurotoxicity
a zajednički kriteriji toksičnosti nacionalnog instituta za rak (ctc v2.0; nci 1998) b osim neurotoksičnosti

clinically relevant ctc toxicities that were reported in < 1 % of the patients that were randomly assigned to pemetrexed include supraventricular arrhythmias.
klinički značajne toksičnosti prema ctc kriterijima prijavljene u < 1 % bolesnika randomiziranih u skupinu koja je primala pemetreksed uključuju supraventrikularne aritmije.

clinically relevant ctc toxicities that were reported in ≥ 1 % and < 5 % of the patients that were randomly assigned to pemetrexed include: infection without neutropenia, febrile neutropenia, allergic reaction/hypersensitivity, increased creatinine, motor neuropathy, sensory neuropathy, erythema multiforme, and abdominal pain.
među klinički značajne oblike toksičnosti prema ctc kriterijima, prijavljene u ≥ 1% i ≤ 5% bolesnika randomiziranih u skupinu koja je primala pemetreksed, ubrajaju se: infekcija bez neutropenije, neutropenijska vrućica, alergijska reakcija/preosjetljivost, povišene vrijednosti kreatinina, motorička neuropatija, senzorna neuropatija, multiformni eritem i bol u abdomenu.